Similar EMT-suppressive effects upon AMIGO2 silencing have recently been reported in other malignancies, including melanoma and gastric cancer 20, 42, while comparable EMT-inhibitory outcomes were also observed in bladder cancer following AMIGO2 knockdown 47. This evidence concerns the gene AMIGO2 and urinary bladder cancer.